GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dimed SA Distribuidora de Medicamentos (BSP:PNVL3) » Definitions » 3-Year ROIIC %

Dimed Distribuidora de Medicamentos (BSP:PNVL3) 3-Year ROIIC % : 9.49% (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Dimed Distribuidora de Medicamentos 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Dimed Distribuidora de Medicamentos's 3-Year ROIIC % for the quarter that ended in Dec. 2023 was 9.49%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Dimed Distribuidora de Medicamentos's 3-Year ROIIC % or its related term are showing as below:

BSP:PNVL3's 3-Year ROIIC % is ranked better than
62.06% of 991 companies
in the Drug Manufacturers industry
Industry Median: 1.37 vs BSP:PNVL3: 9.49

Dimed Distribuidora de Medicamentos 3-Year ROIIC % Historical Data

The historical data trend for Dimed Distribuidora de Medicamentos's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dimed Distribuidora de Medicamentos 3-Year ROIIC % Chart

Dimed Distribuidora de Medicamentos Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.94 2.92 0.91 3.52 9.49

Dimed Distribuidora de Medicamentos Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 9.49 - - -

Competitive Comparison of Dimed Distribuidora de Medicamentos's 3-Year ROIIC %

For the Drug Manufacturers - General subindustry, Dimed Distribuidora de Medicamentos's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dimed Distribuidora de Medicamentos's 3-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dimed Distribuidora de Medicamentos's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Dimed Distribuidora de Medicamentos's 3-Year ROIIC % falls into.


;
;

Dimed Distribuidora de Medicamentos 3-Year ROIIC % Calculation

Dimed Distribuidora de Medicamentos's 3-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 170.8635072 (Dec. 2023) - 99.1997314 (Dec. 2020) )/( 2102.366 (Dec. 2023) - 1347.476 (Dec. 2020) )
=71.6637758/754.89
=9.49%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Dimed Distribuidora de Medicamentos  (BSP:PNVL3) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Dimed Distribuidora de Medicamentos 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Dimed Distribuidora de Medicamentos's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dimed Distribuidora de Medicamentos Business Description

Traded in Other Exchanges
N/A
Address
Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. Its segments are divided into Retail, Wholesale and Corporate. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. The Wholesale segment is the distributor of drugs in Brazil. The Corporate segment includes Wholesale and Retail, as well as the subsidiary Lifar. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.

Dimed Distribuidora de Medicamentos Headlines

No Headlines